logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Atrial Fibrillation

    FiltersReset Filters
    34 results

    • apixaban

      (Apixaban)
      Macleods Pharmaceuticals Limited
      Usage: Apixaban is indicated for reducing stroke and systemic embolism risk in nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis following hip or knee surgery, and treatment of deep vein thrombosis and pulmonary embolism. It also reduces the risk of recurrent DVT and pulmonary embolism after initial therapy.

    • corvert

      (ibutilide fumarate)
      Pharmacia & Upjohn Company LLC
      Usage: CORVERT Injection is indicated for the rapid conversion of recent-onset atrial fibrillation or atrial flutter to sinus rhythm. It is less effective in patients with arrhythmias lasting longer than 90 days, as its effectiveness in such cases has not been established.

    • dabigatran etexilate

      (dabigatran etexilate)
      Apotex Corp.
      Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing their recurrence, and prophylaxis following hip replacement surgery in adult patients.

    • dabigatran etexilate

      (Dabigatran Etexilate)
      Mylan Pharmaceuticals Inc.
      Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.

    • dabigatran etexilate

      (Dabigatran etexilate)
      Dr. Reddy's Laboratories Inc.
      Usage: Dabigatran etexilate capsules are indicated for reducing stroke risk in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, providing prophylaxis following hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to under 18 years.

    • dabigatran etexilate

      (Dabigatran Etexilate)
      Alembic Pharmaceuticals Limited
      Usage: Dabigatran etexilate is indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing recurrence of these conditions, and prophylaxis following hip replacement surgery in adults.

    • diltiazem hydrochloride

      (Diltiazem Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Diltiazem Hydrochloride Injection is indicated for temporary control of rapid ventricular rates in atrial fibrillation or flutter and for converting paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. Continuous monitoring is essential during administration, with emergency equipment on hand.

    • dofetilide

      (Dofetilide)
      VGYAAN Pharmaceuticals LLC
      Usage: Dofetilide Capsules are indicated for maintaining normal sinus rhythm and delaying recurrence of atrial fibrillation/atrial flutter in symptomatic patients who have been converted to sinus rhythm. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm but are ineffective in paroxysmal cases.

    • dofetilide

      (DOFETILIDE)
      NorthStar RxLLC
      Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm in patients with atrial fibrillation/atrial flutter (AF/AFl) post-conversion and for converting AF/AFl to normal sinus rhythm. It is intended for symptomatic patients and is not effective for paroxysmal AF.

    • dofetilide

      (Dofetilide)
      EXELAN PHARMACEUTICALS, INC.
      Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm and delaying the recurrence of atrial fibrillation/atrial flutter in symptomatic patients after conversion. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm, though not effective for paroxysmal atrial fibrillation.